Since 1986 when we first opened, Boston IVF has conducted ground-breaking research that has contributed to vast improvements in assisted reproductive technologies and fertility treatment. Patients at Boston IVF benefit from working with the experts who conducted these studies; when appropriate, patients are invited to participate in research studies as well. Below are brief descriptions of  current or expired trials conducted by Boston IVF. The ISIS and FORTT trials were done in affiliation with Harvard Medical School, Dartmouth College and Beth Israel Deaconess Medical Center (BIDMC) and werefunded by the National Institutes of Health (NIH), the primary agency for conducting medical research.

FASTT TRIAL: Now completed. The FASTT trial was the largest-ever funded trial by the National Institutes of Health (NIH) in the field of infertility. The purpose of this randomized prospective clinical trial was to determine whether an infertility treatment that moves quickly to In Vitro Fertilization (IVF) is more cost effective than the usual treatment strategy which includes various combinations of infertility drugs and intrauterine insemination (IUI) prior to utilizing In Vitro Fertilization.

FORTT (Forty and Over Infertility Treatment) TRIAL: Now completed. This study will help determine the best treatment for infertile women between the ages of 38 and 42.

ISIS STUDY: The purpose of this study is to evaluate the link between lifestyle and fertility. This study is currently recruiting women age 20-34 and their male partners who are planning their first pregnancy. Click here for more information on this trial. Additionally, Boston IVF initiates new research projects on a regular basis. If you are interested in enrolling in a study or learning more about our research, please speak with your Boston IVF physician or our Study Coordinator, Kristin B.